Canine Parvovirus(CPV) Inhibitor Tablets

Product Name: Canine Parvovirus(CPV) Inhibitor Tablets

Indication: For the specific treatment of Canine Parvovirus(CPV) infection in cats.
This product is a first-line therapeutic agent designed to directly inhibit Canine Parvovirus(CPV) replication,rapidly reduce viral load, and is a core component of the standard treatment protocol for feline panleukopenia.
It must be initiated as early as possible upon diagnosis and used in conjunction with comprehensive
supportive care (including intravenous fluid therapy, antibiotics, antiemetics, etc.) to achieve optimal therapeutic outcomes.

Dosage: For oral use only.
The recommended dosage is 1 tablet per 4 kg of body weight, administered every 12 hours.
Duration of Treatment: The recommended treatment course is 5 to 7 days.
Administration should continue for at least 72 hours after the complete resolution of clinical symptoms and until two consecutive negative fecal antigen tests are obtained, as determined by the attending veterinarian.

Body weight of dogs (kg)	Dosage per Administration	Administration Interval
BW≤2	½ tablet	Twice a day (every 12 hours)
2<BW≤4	1 tablet
4<BW≤8	1.5 tablets
8≤BW	According to weight, 1/4 tablet per kg

Withdrawal:
Not applicable
Package:
30 tablets per bottle
Storage:
Store tightly sealed below 25℃
Shelf life: 2 years
Warning：
This product contains a highconcentration, last-resort antibiotic.Accidental ingestion by humans may cause serious health effects and contribute to antibiotic resistance. Seek medical advice immediately if ingested.

Important Notes
(1)Prescription-only: This is a prescription-only medicine.Administration MUST be under the direct supervision and guidance of a veterinarian.
(2)Complete the Course: Even if symptoms improve, administer the full course as prescribed to prevent relapse and resistance development.
(3)Monitoring: Regular monitoring of renal function and overall clinical response is essential during treatment.
(4)Adverse Reactions: Potential side effects may include vomiting, diarrhea, loss of appetite, or in rare cases neurological signs (e.g., tremors). Discontinue use and contact your veterinarian immediately if adverse reactions occur.
(5)THERAPEUTIC WARNING: While this product is a specific antiviral agent, the successful management of feline panleukopenia critically depends on timely and aggressive supportive care to address dehydration, secondary infections, and nutritional support. This product does not replace essential fluid and electrolyte therapy.

For animal use only.